Skip to main content
Erschienen in: Current Fungal Infection Reports 2/2024

31.01.2024 | Review

The Importance of Candida auris in Skin

verfasst von: Alexandra M. Montoya

Erschienen in: Current Fungal Infection Reports | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Candida auris has been recognized recently as an agent of outbreaks of severe disease, usually in healthcare environments. As a multi-drug resistant pathogen, cases are associated to high mortality rates. The human skin is considered to be the main reservoir of this yeast in the context of disease. This work aims to review the C. auris colonization prevalence, patterns, and mechanisms, as well as give a brief account of the methods for screening and control being used.

Recent Findings

There are high rates of skin colonization involving individuals residing in multi-occupancy healthcare facilities. Although the axilla, groin, and nares are considered the main niches for colonization, there is evidence of C. auris presence in other anatomical sites. Ex vivo and in vivo models have shown a higher burden of C. auris in folds and crevices of the skin, as well as a capacity to burrow within skin follicles. Colonization of C. auris relates to other changes in microbiota, namely increased Candida spp. and Gram-negative bacteria relative abundance.

Summary

As current therapies are largely ineffective against C. auris, prevention is today the only control measure to curtail disease and outbreaks. Strategies for proper screening should be established to better detect potential cases in vulnerable groups, and protocols for effective decolonization prophylaxis and reestablishing of healthy skin microbiota should be a priority. Further studies on C. auris skin colonization are needed, especially those related to its patterns and mechanisms, to better understand the factors that favor this altered state.
Literatur
1.
Zurück zum Zitat Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4.CrossRefPubMed Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4.CrossRefPubMed
2.
Zurück zum Zitat Osei SJ. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen. 2018;7(4):e00578.CrossRef Osei SJ. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen. 2018;7(4):e00578.CrossRef
3.
Zurück zum Zitat Lone SA, Ahmad A. Candida auris—the growing menace to global health. Mycoses. 2019;62(8):620–37.CrossRefPubMed Lone SA, Ahmad A. Candida auris—the growing menace to global health. Mycoses. 2019;62(8):620–37.CrossRefPubMed
4.
Zurück zum Zitat Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–40.CrossRefPubMed Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–40.CrossRefPubMed
5.
Zurück zum Zitat de Cássia Orlandi Sardi J, Silva DR, Soares Mendes-Giannini MJ, Rosalen PL. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb Pathog. 2018;125:116–21.CrossRefPubMed de Cássia Orlandi Sardi J, Silva DR, Soares Mendes-Giannini MJ, Rosalen PL. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb Pathog. 2018;125:116–21.CrossRefPubMed
6.
Zurück zum Zitat Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, et al. Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol. 2017;55(2):638–40.CrossRefPubMedPubMedCentral Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, et al. Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol. 2017;55(2):638–40.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1):e00029.CrossRefPubMed Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1):e00029.CrossRefPubMed
9.
Zurück zum Zitat Vatanshenassan M, Boekhout T, Meis JF, Berman J, Chowdhary A, Ben-Ami R, et al. Candida auris identification and rapid antifungal susceptibility testing against echonocandins by MALDI-TOF MS. Front Cell Infect Microbiol. 2019;9:20.CrossRefPubMedPubMedCentral Vatanshenassan M, Boekhout T, Meis JF, Berman J, Chowdhary A, Ben-Ami R, et al. Candida auris identification and rapid antifungal susceptibility testing against echonocandins by MALDI-TOF MS. Front Cell Infect Microbiol. 2019;9:20.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Chow NA, Muñoz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. MBio. 2020;11(2):e03364–19.CrossRefPubMedPubMedCentral Chow NA, Muñoz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. MBio. 2020;11(2):e03364–19.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405–11.CrossRefPubMedPubMedCentral Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405–11.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013-August 2016. Am J Transpl. 2017;17:296–9.CrossRef Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013-August 2016. Am J Transpl. 2017;17:296–9.CrossRef
16.
Zurück zum Zitat Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, Southwick K, et al. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis. 2018;24(10):1816–24.CrossRefPubMedPubMedCentral Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, Southwick K, et al. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis. 2018;24(10):1816–24.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Shuping L, Maphanga TG, Naicker SD, Mpembe R, Ngoma N, Velaphi S, et al. High prevalence of Candida auris colonization during protracted neonatal unit outbreak. South Africa. Emerg Infect Dis. 2023;29(9):1913–6.PubMed Shuping L, Maphanga TG, Naicker SD, Mpembe R, Ngoma N, Velaphi S, et al. High prevalence of Candida auris colonization during protracted neonatal unit outbreak. South Africa. Emerg Infect Dis. 2023;29(9):1913–6.PubMed
18.
Zurück zum Zitat Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018;379(14):1322–31.CrossRefPubMed Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018;379(14):1322–31.CrossRefPubMed
19.
Zurück zum Zitat Sexton DJ, Bentz ML, Welsh RM, Derado G, Furin W, Rose LJ, et al. Positive correlation between Candida auris skin-colonization burden and environmental contamination at a ventilator-capable skilled nursing facility in Chicago. Clin Infect Dis. 2021;73(7):1142–8.CrossRefPubMedPubMedCentral Sexton DJ, Bentz ML, Welsh RM, Derado G, Furin W, Rose LJ, et al. Positive correlation between Candida auris skin-colonization burden and environmental contamination at a ventilator-capable skilled nursing facility in Chicago. Clin Infect Dis. 2021;73(7):1142–8.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Proctor DM, Dangana T, Sexton DJ, Fukuda C, Yelin RD, Stanley M, et al. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med. 2021;27(8):1401–9.CrossRefPubMedPubMedCentral Proctor DM, Dangana T, Sexton DJ, Fukuda C, Yelin RD, Stanley M, et al. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med. 2021;27(8):1401–9.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zhai WF, Huang Y, Zhang XL, Fei WM, Chang YL, Cheng SS, et al. Profile of the skin microbiota in a healthy Chinese population. J Dermatol. 2018;45(11):1289–300.CrossRefPubMed Zhai WF, Huang Y, Zhang XL, Fei WM, Chang YL, Cheng SS, et al. Profile of the skin microbiota in a healthy Chinese population. J Dermatol. 2018;45(11):1289–300.CrossRefPubMed
22.
Zurück zum Zitat Huang X, Welsh RM, Deming C, Proctor DM, Thomas PJ, Gussin GM, et al. Skin metagenomic sequence analysis of early Candida auris outbreaks in U.S. nursing homes. mSphere. 2021;6(4):e00287–21.CrossRefPubMedPubMedCentral Huang X, Welsh RM, Deming C, Proctor DM, Thomas PJ, Gussin GM, et al. Skin metagenomic sequence analysis of early Candida auris outbreaks in U.S. nursing homes. mSphere. 2021;6(4):e00287–21.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367–70.CrossRefPubMedPubMedCentral Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367–70.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Zhu Y, O’Brien B, Leach L, Clarke A, Bates M, Adams E, et al. Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: impact and lessons learned. J Clin Microbiol. 2020;58:e01503–19.CrossRefPubMedPubMedCentral Zhu Y, O’Brien B, Leach L, Clarke A, Bates M, Adams E, et al. Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: impact and lessons learned. J Clin Microbiol. 2020;58:e01503–19.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Huang X, Hurabielle C, Drummond RA, Bouladoux N, Desai JV, Sim CK, et al. Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe. 2021;29(2):210–21.CrossRefPubMed Huang X, Hurabielle C, Drummond RA, Bouladoux N, Desai JV, Sim CK, et al. Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe. 2021;29(2):210–21.CrossRefPubMed
26.
Zurück zum Zitat Eix EF, Johnson CJ, Wartman KM, Kernien JF, Meudt JJ, Shanmuganayagam D, et al. Ex vivo human and porcine skin effectively model Candida auris colonization, differentiating robust and poor fungal colonizers. J Infect Dis. 2022;225(10):1791–5.CrossRefPubMedPubMedCentral Eix EF, Johnson CJ, Wartman KM, Kernien JF, Meudt JJ, Shanmuganayagam D, et al. Ex vivo human and porcine skin effectively model Candida auris colonization, differentiating robust and poor fungal colonizers. J Infect Dis. 2022;225(10):1791–5.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Wang X, Bing J, Zheng Q, Zhang F, Liu J, Yue H, et al. The first isolate of Candida auris in China: clinical and biological aspects article. Emerg Microbes Infect. 2018;7(1):93.CrossRefPubMedPubMedCentral Wang X, Bing J, Zheng Q, Zhang F, Liu J, Yue H, et al. The first isolate of Candida auris in China: clinical and biological aspects article. Emerg Microbes Infect. 2018;7(1):93.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61(5):e02396–16.CrossRefPubMedPubMedCentral Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61(5):e02396–16.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328–31.CrossRefPubMedPubMedCentral Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328–31.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Horton MV, Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, et al. Candida auris forms high-burden biofilms in skin niche conditions and on porcine skin. mSphere. 2020;5(1) Horton MV, Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, et al. Candida auris forms high-burden biofilms in skin niche conditions and on porcine skin. mSphere. 2020;5(1)
31.
Zurück zum Zitat Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistance, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996–3005.CrossRefPubMedPubMedCentral Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistance, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55:2996–3005.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Bravo Ruiz G, Ross ZK, Gow NAR, Lorenz A. Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint. mSphere. 2020;5(2):e00151–20.CrossRefPubMedPubMedCentral Bravo Ruiz G, Ross ZK, Gow NAR, Lorenz A. Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint. mSphere. 2020;5(2):e00151–20.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva P. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol. 2018;56(12):1–6.CrossRef Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva P. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol. 2018;56(12):1–6.CrossRef
34.
Zurück zum Zitat Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlina DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445–52.CrossRefPubMedPubMedCentral Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlina DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55(8):2445–52.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Kordalewska M, Lee A, Zhao Y, Perlin DS. Detection of Candida auris antifungal drug resistance markers directly from clinical skin swabs. Antimicrob Agents Chemother. 2019;63(12):1–5.CrossRef Kordalewska M, Lee A, Zhao Y, Perlin DS. Detection of Candida auris antifungal drug resistance markers directly from clinical skin swabs. Antimicrob Agents Chemother. 2019;63(12):1–5.CrossRef
36.
Zurück zum Zitat Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Control Hosp Epidemiol. 2019;40(3):380–2.CrossRefPubMed Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Control Hosp Epidemiol. 2019;40(3):380–2.CrossRefPubMed
37.
Zurück zum Zitat Fu L, Le T, Liu Z, Wang L, Guo H, Yang J, et al. Different efficacies of common disinfection methods against Candida auris and other Candida species. J Infect Public Heal. 2020;13:730–6.CrossRef Fu L, Le T, Liu Z, Wang L, Guo H, Yang J, et al. Different efficacies of common disinfection methods against Candida auris and other Candida species. J Infect Public Heal. 2020;13:730–6.CrossRef
38.
Zurück zum Zitat Gülmez D, Brown JL, Butcher MC, Delaney C, Kean R, Ramage G, et al. Investigating dual-species Candida auris and Staphylococcal biofilm antiseptic challenge. Antibiotics. 2022;11:931.CrossRefPubMedPubMedCentral Gülmez D, Brown JL, Butcher MC, Delaney C, Kean R, Ramage G, et al. Investigating dual-species Candida auris and Staphylococcal biofilm antiseptic challenge. Antibiotics. 2022;11:931.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017;60:758–63.CrossRefPubMed Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017;60:758–63.CrossRefPubMed
40.
Zurück zum Zitat Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Effectiveness of disinfectants against Candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38(10):1240–3.CrossRefPubMed Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Effectiveness of disinfectants against Candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38(10):1240–3.CrossRefPubMed
41.
Zurück zum Zitat Gall E, Long A, Hall KK. Chlorhexidine bathing strategies for multidrug-resistant organisms: a summary of recent evidence. J Patient Saf. 2020;16(3 1 Suppl):S16–22.CrossRefPubMedPubMedCentral Gall E, Long A, Hall KK. Chlorhexidine bathing strategies for multidrug-resistant organisms: a summary of recent evidence. J Patient Saf. 2020;16(3 1 Suppl):S16–22.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Importance of Candida auris in Skin
verfasst von
Alexandra M. Montoya
Publikationsdatum
31.01.2024
Verlag
Springer US
Erschienen in
Current Fungal Infection Reports / Ausgabe 2/2024
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-024-00487-3

Weitere Artikel der Ausgabe 2/2024

Current Fungal Infection Reports 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.